$98.3 Million is the total value of Belmont Global Advisors, Inc.'s 58 reported holdings in Q1 2016. The portfolio turnover from Q4 2015 to Q1 2016 was 213.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| XON | Buy | INTREXON CORP | $12,890,000 | +143.9% | 380,350 | +117.0% | 13.11% | +91.5% |
| ZIOP | Buy | ZIOPHARM ONCOLOGY INCcall | $11,724,000 | +44.7% | 1,580,000 | +62.1% | 11.93% | +13.6% |
| ZIOP | Buy | ZIOPHARM ONCOLOGY INC | $11,672,000 | -1.3% | 1,573,040 | +10.5% | 11.87% | -22.5% |
| XON | Buy | INTREXON CORPcall | $7,625,000 | +321.5% | 225,000 | +275.0% | 7.76% | +230.9% |
| XLB | New | SELECT SECTOR SPDR TRput | $4,481,000 | – | 100,000 | +100.0% | 4.56% | – |
| XLP | New | SELECT SECTOR SPDR TRput | $3,449,000 | – | 65,000 | +100.0% | 3.51% | – |
| SMH | New | MARKET VECTORS ETF TRput | $2,754,000 | – | 50,000 | +100.0% | 2.80% | – |
| FIZZ | New | NATIONAL BEVERAGE CORP | $2,751,000 | – | 65,000 | +100.0% | 2.80% | – |
| HOG | New | HARLEY DAVIDSON INCput | $2,567,000 | – | 50,000 | +100.0% | 2.61% | – |
| FRO | New | FRONTLINE LTDcall | $2,511,000 | – | 300,000 | +100.0% | 2.55% | – |
| USO | New | UNITED STATES OIL FUND LPput | $2,425,000 | – | 250,000 | +100.0% | 2.47% | – |
| GE | New | GENERAL ELECTRIC COput | $2,384,000 | – | 75,000 | +100.0% | 2.42% | – |
| XLU | New | SELECT SECTOR SPDR TRput | $1,985,000 | – | 40,000 | +100.0% | 2.02% | – |
| FBIO | Buy | FORTRESS BIOTECH INC | $1,891,000 | +77.1% | 610,000 | +59.4% | 1.92% | +39.0% |
| HD | Buy | HOME DEPOT INC | $1,608,000 | +102.8% | 12,050 | +100.8% | 1.64% | +59.3% |
| TVIX | Buy | CREDIT SUISSE AG NASSAU BRH | $1,383,000 | +10.5% | 315,000 | +57.5% | 1.41% | -13.3% |
| VBTX | Buy | VERITEX HLDGS INC | $1,369,000 | -7.4% | 94,229 | +3.3% | 1.39% | -27.3% |
| SGYPQ | Buy | SYNERGY PHARMACEUTICALS DEL | $1,104,000 | +36.6% | 400,000 | +180.7% | 1.12% | +7.3% |
| ORLY | Buy | O REILLY AUTOMOTIVE INC NEW | $1,098,000 | +8.3% | 4,012 | +0.3% | 1.12% | -15.0% |
| LJPC | Buy | LA JOLLA PHARMACEUTICAL CO | $1,045,000 | +3.2% | 50,000 | +33.3% | 1.06% | -19.0% |
| MCD | New | MCDONALDS CORP | $943,000 | – | 7,500 | +100.0% | 0.96% | – |
| NKE | Buy | NIKE INCcl b | $922,000 | +5.4% | 15,000 | +7.1% | 0.94% | -17.3% |
| FATE | Buy | FATE THERAPEUTICS INC | $868,000 | +56.1% | 482,000 | +192.1% | 0.88% | +22.6% |
| ACAD | New | ACADIA PHARMACEUTICALS INC | $839,000 | – | 30,000 | +100.0% | 0.85% | – |
| DY | New | DYCOM INDS INC | $808,000 | – | 12,500 | +100.0% | 0.82% | – |
| MSFT | New | MICROSOFT CORP | $693,000 | – | 12,555 | +100.0% | 0.70% | – |
| SSO | New | PROSHARES TR | $619,000 | – | 9,700 | +100.0% | 0.63% | – |
| AMZN | New | AMAZON COM INC | $598,000 | – | 1,008 | +100.0% | 0.61% | – |
| PANW | New | PALO ALTO NETWORKS INC | $571,000 | – | 3,500 | +100.0% | 0.58% | – |
| JCPNQ | New | PENNEY J C INC | $553,000 | – | 50,000 | +100.0% | 0.56% | – |
| IBM | New | INTERNATIONAL BUSINESS MACHS | $530,000 | – | 3,500 | +100.0% | 0.54% | – |
| TJX | New | TJX COS INC NEW | $529,000 | – | 6,750 | +100.0% | 0.54% | – |
| TGT | New | TARGET CORP | $514,000 | – | 6,250 | +100.0% | 0.52% | – |
| IDRA | New | IDERA PHARMACEUTICALS INC | $495,000 | – | 250,000 | +100.0% | 0.50% | – |
| APHB | Buy | AMPLIPHI BIOSCIENCES CORP | $492,000 | +57.7% | 125,000 | +59.6% | 0.50% | +23.8% |
| KO | New | COCA COLA CO | $464,000 | – | 10,000 | +100.0% | 0.47% | – |
| FTNT | New | FORTINET INC | $459,000 | – | 15,000 | +100.0% | 0.47% | – |
| BHK | New | BLACKROCK CORE BD TR | $447,000 | – | 33,364 | +100.0% | 0.46% | – |
| CHKP | New | CHECK POINT SOFTWARE TECH LTord | $437,000 | – | 5,000 | +100.0% | 0.44% | – |
| XYL | New | XYLEM INC | $409,000 | – | 10,000 | +100.0% | 0.42% | – |
| CUDA | New | BARRACUDA NETWORKS INC | $385,000 | – | 25,000 | +100.0% | 0.39% | – |
| XLF | Buy | SELECT SECTOR SPDR TRsbi int-finl | $326,000 | +13.2% | 14,500 | +19.8% | 0.33% | -11.0% |
| HALO | New | HALOZYME THERAPEUTICS INCcall | $311,000 | – | 32,800 | +100.0% | 0.32% | – |
| HALO | New | HALOZYME THERAPEUTICS INC | $284,000 | – | 30,000 | +100.0% | 0.29% | – |
| DCO | New | DUCOMMUN INC DEL | $229,000 | – | 15,000 | +100.0% | 0.23% | – |
| HTH | New | HILLTOP HOLDINGS INC | $208,000 | – | 11,000 | +100.0% | 0.21% | – |
| ATRC | New | ATRICURE INC | $168,000 | – | 10,000 | +100.0% | 0.17% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-05-16
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ZIOPHARM ONCOLOGY INC | 12 | Q3 2016 | 21.1% |
| INTREXON CORP | 12 | Q3 2016 | 13.1% |
| FACEBOOK INC | 12 | Q3 2016 | 3.4% |
| PIMCO DYNAMIC INCOME FD | 11 | Q3 2016 | 2.2% |
| SYNERGY PHARMACEUTICALS DEL | 11 | Q3 2016 | 1.4% |
| CBIZ INC | 11 | Q2 2016 | 0.2% |
| ZIOPHARM ONCOLOGY INC | 10 | Q3 2016 | 14.8% |
| LA JOLLA PHARMACEUTICAL CO | 10 | Q2 2016 | 3.4% |
| APPLE INC | 10 | Q3 2016 | 3.2% |
| MEDGENICS INC | 10 | Q2 2016 | 2.1% |
View Belmont Global Advisors, Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2016-11-14 |
| 13F-HR | 2016-08-15 |
| 13F-HR | 2016-05-16 |
| 13F-HR | 2016-02-16 |
| 13F-HR | 2015-11-16 |
| 13F-HR | 2015-08-14 |
| 13F-HR | 2015-05-15 |
| 13F-HR | 2015-02-17 |
| 13F-HR | 2014-11-14 |
| 13F-HR | 2014-08-14 |
View Belmont Global Advisors, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.